Jeong M, Jeong M, Kim J, Cho S, Lee K, Park S, et al. TCTP protein degradation by targeting mTORC1 and signaling through S6K, Akt, and Plk1 sensitizes lung cancer cells to DNA-damaging drugs. Sci Rep. 2021;11:20812 pubmed publisher

Pande S, Browne G, Padmanabhan S, Zaidi S, Lian J, Van Wijnen A, et al. Oncogenic cooperation between PI3K/Akt signaling and transcription factor Runx2 promotes the invasive properties of metastatic breast cancer cells. J Cell Physiol. 2013;228:1784-92 pubmed publisher

Miyawaki T, Ofengeim D, Noh K, Latuszek Barrantes A, Hemmings B, Follenzi A, et al. The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death. Nat Neurosci. 2009;12:618-26 pubmed publisher

Ramaswamy S, Nakamura N, Vazquez F, Batt D, Perera S, Roberts T, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A. 1999;96:2110-5 pubmed